IBDEI2HE ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39623,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,39624,0)
 ;;=C81.90^^152^2000^90
 ;;^UTILITY(U,$J,358.3,39624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39624,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,39624,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,39624,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,39625,0)
 ;;=D89.2^^152^2000^91
 ;;^UTILITY(U,$J,358.3,39625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39625,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,39625,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,39625,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,39626,0)
 ;;=D05.12^^152^2000^94
 ;;^UTILITY(U,$J,358.3,39626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39626,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,39626,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,39626,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,39627,0)
 ;;=D05.11^^152^2000^95
 ;;^UTILITY(U,$J,358.3,39627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39627,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,39627,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,39627,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,39628,0)
 ;;=D05.10^^152^2000^96
 ;;^UTILITY(U,$J,358.3,39628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39628,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,39628,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,39628,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,39629,0)
 ;;=D50.0^^152^2000^97
 ;;^UTILITY(U,$J,358.3,39629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39629,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,39629,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,39629,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,39630,0)
 ;;=D50.9^^152^2000^98
 ;;^UTILITY(U,$J,358.3,39630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39630,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,39630,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,39630,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,39631,0)
 ;;=C46.9^^152^2000^99
 ;;^UTILITY(U,$J,358.3,39631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39631,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,39631,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,39631,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,39632,0)
 ;;=C22.0^^152^2000^100
 ;;^UTILITY(U,$J,358.3,39632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39632,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,39632,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,39632,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,39633,0)
 ;;=D05.02^^152^2000^101
 ;;^UTILITY(U,$J,358.3,39633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39633,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,39633,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,39633,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,39634,0)
 ;;=D05.01^^152^2000^102
 ;;^UTILITY(U,$J,358.3,39634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39634,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,39634,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,39634,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,39635,0)
 ;;=D05.00^^152^2000^103
 ;;^UTILITY(U,$J,358.3,39635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39635,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,39635,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,39635,2)
 ;;=^5001926
